September 19, 2022
PAR-21-335 - Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
This notice is to alert potential applicants to the early expiration of the Funding Opportunity Announcement (FOA) PAR-21-335 "Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)". Effective immediately, the remaining receipt dates for this FOA have been canceled. This FOA will now expire on October 1, 2022.
The following section of PAR-21-335 has therefore been modified:
1. Currently Reads:
Part 1. Overview Information
Key Dates
| Application Due Date(s) | November 15, 2021; June 10, 2022; October 11, 2022; February 10, 2023; June 13, 2023; October 11, 2023; June 11, 2024 |
| Scientific Merit Review | March 2022; November 2022; March 2023; July 2023; November 2023; March 2024; November 2024 |
| Advisory Council Review | May 2022; January 2023; May 2023; October 2023; January 2024; May 2024; January 2025 |
| Earliest Start Date | July 2022; April 2023; July 2023; December 2023; April 2024; July 2024; April 2025 |
| Expiration Date | June 12, 2024 |
2. Modified to Read (key change shown in bold italics to indicate early expiration with the removal of remaining receipt dates):
Part 1. Overview Information
Key Dates
|
|||||||||||
Sharmistha Ghosh-Janjigian, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7122
E-mail: [email protected]
and Human Services (HHS)
